Livzon Pharmaceutical Group Inc.
OTC: LVZPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Daping Liu
- Employees
- 9,067
- Headquarters
- Zhuhai, China
- IPO year
- 2018
- Market cap
- $6.1B
- Website
- https://www.livzon.com.cn
Loading LVZPF…
Loading profile data…Frequently asked questions about LVZPF
What does Livzon Pharmaceutical Group Inc. (LVZPF) do?
Livzon Pharmaceutical Group Inc., founded in 1985 and based in Zhuhai, China, is dedicated to the research, development, manufacturing, and distribution of a wide array of pharmaceutical products, active pharmaceutical ingredients (APIs), and related intermediates. The company's diverse range of medications includes Ilaprazole enteric-coated tab...
Where does LVZPF trade?
Livzon Pharmaceutical Group Inc. (LVZPF) trades on the Other OTC.
What sector is LVZPF in?
Livzon Pharmaceutical Group Inc. (LVZPF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Livzon Pharmaceutical Group Inc.?
Daping Liu is the chief executive officer of Livzon Pharmaceutical Group Inc. (LVZPF).
Where is Livzon Pharmaceutical Group Inc. headquartered?
Livzon Pharmaceutical Group Inc. is headquartered in China.
Does LVZPF pay a dividend?
Yes — Livzon Pharmaceutical Group Inc. (LVZPF) paid a trailing twelve-month dividend of USD 0.21 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did LVZPF go public?
Livzon Pharmaceutical Group Inc. (LVZPF) completed its initial public offering in 2018.